Clinical Trials Directory

Trials / Completed

CompletedNCT07022730

Prophylactic Noradrenaline Infusion and Its Impact on Post-induction Hypotension

The Novel Use of Prophylactic Noradrenaline Infusion and Its Impact on Post-induction Hypotension in Patients With Surgical Sepsis, a Double Blind Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Not accepted

Summary

researchers aim to evaluate the influence of prophylactic noradrenaline infusion on post-induction hypotension

Detailed description

If post-induction hypotension is not addressed promptly, it can lead to severe complications such as reduced blood flow, acute kidney damage, and myocardial ischemia. As a result, early detection and proactive intervention are crucial. Researchers of the current study decided to investigate impact of noradrenaline administered as a prophylaxis on post induction hypotension

Conditions

Interventions

TypeNameDescription
DRUGNoradrenaline 0.2 mcg/kg/min at 5 minutes before inductionnoradrenaline will be given at a rate of 0.2 mcg/kg/min that will start 5 minutes before induction

Timeline

Start date
2025-06-22
Primary completion
2025-09-17
Completion
2025-09-17
First posted
2025-06-15
Last updated
2025-09-18

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07022730. Inclusion in this directory is not an endorsement.

Prophylactic Noradrenaline Infusion and Its Impact on Post-induction Hypotension (NCT07022730) · Clinical Trials Directory